A detailed history of Tidemark, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Tidemark, LLC holds 65 shares of GH stock, worth $2,382. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65
Previous 15 333.33%
Holding current value
$2,382
Previous $433,000 99.77%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$22.3 - $36.29 $1,115 - $1,814
50 Added 333.33%
65 $1,000
Q2 2024

Aug 12, 2024

SELL
$16.07 - $31.84 $3,069 - $6,081
-191 Reduced 92.72%
15 $433,000
Q1 2024

May 13, 2024

SELL
$17.13 - $26.91 $1,507 - $2,368
-88 Reduced 29.93%
206 $4.25 Million
Q4 2023

Feb 09, 2024

BUY
$21.58 - $29.5 $6,344 - $8,673
294 New
294 $7.95 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.75B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Tidemark, LLC Portfolio

Follow Tidemark, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tidemark, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tidemark, LLC with notifications on news.